Cargando…
Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
Urothelial carcinoma, the most common histologic subtype of bladder cancer in the United States, most frequently presents as non–muscle invasive disease. Initially, therapy involves transurethral endoscopic resection and subsequent intravesical therapies with extended surveillance for high-risk dise...
Autores principales: | Frydenlund, Noah, Zakharia, Yousef, Garje, Rohan, Dahmoush, Laila, O’Donnell, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194919/ https://www.ncbi.nlm.nih.gov/pubmed/30349834 http://dx.doi.org/10.1177/2324709618806332 |
Ejemplares similares
-
PARP Inhibitors in Prostate and Urothelial Cancers
por: Garje, Rohan, et al.
Publicado: (2020) -
The Future of Immunotherapy-Based Combination Therapy in Metastatic Renal Cell Carcinoma
por: Garje, Rohan, et al.
Publicado: (2020) -
Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer
por: Garje, Rohan, et al.
Publicado: (2020) -
Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019) -
Metastatic papillary thyroid carcinoma of the mandible: Case report and literature review
por: Khoozestani, Neda Kardouni, et al.
Publicado: (2019)